Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Nov. 01, 2025	Nov. 02, 2024
Cash flows from operating activities:
Net income (loss)	$ 146,035	$ (13,765)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	12,027	9,218
Share-based compensation	80,779	33,303
Warrant contra revenue	0	5,828
Write-downs for excess and obsolete inventory	8,120	2,205
Changes in operating assets and liabilities:
Accounts receivable	(83,053)	(22,114)
Inventories	(66,403)	(12,611)
Other current assets	(1,917)	(2,517)
Other non-current assets	1,713	1,216
Accounts payable	5,630	(1,429)
Accrued compensation and benefits, other current liabilities and other non-current liabilities	12,902	3,715
Net cash provided by operating activities	115,833	3,049
Cash flows from investing activities:
Purchases of property and equipment	(26,009)	(27,811)
Maturities of short-term investments	64,010	313,061
Purchases of short-term investments	(115,000)	(113,716)
Business acquisition, net of cash acquired	(82,564)	0
Net cash provided by (used in) investing activities	(159,563)	171,534
Cash flows from financing activities:
Payments on technology license obligations	(4,812)	(4,556)
Proceeds from ordinary shares issued under At-The-Market Offering, net of issuance costs	384,620	0
Proceeds from employee share incentive plans	5,177	4,384
Tax withheld related to RSU settlement	(10,061)	(2,250)
Net cash provided by (used in) financing activities	374,924	(2,422)
Effect of exchange rate changes on cash	53	134
Net increase in cash and cash equivalents	331,247	172,295
Cash and cash equivalents at beginning of the period	236,328	66,942
Cash and cash equivalents at end of the period	567,575	239,237
Supplemental cash flow information:
Purchases of property and equipment included in accounts payable, other current liabilities and other non-current liabilities	$ 9,467	$ 7,966